Dendritic cell recruitment and activation in autoimmunity

Journal of Autoimmunity

Volumn 85, Issue , 2017, Pages 126-140

  Sozzani, Silvano ^a,b   Del Prete, Annalisa ^a,b   Bosisio, Daniela ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME B; INTERFERON; INTERFERON STIMULATED GENE FACTOR 3; TOLL LIKE RECEPTOR; CYTOKINE;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL MATURATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LUPUS ERYTHEMATOSUS; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TISSUE INJURY; ANIMAL; IMMUNOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE;

EID: 85026523925     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2017.07.012     Document Type: Review

References (256)

1. Steinman, R.M., Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 30 (2012), 1–22.
2. Villani, A.C., Satija, R., Reynolds, G., Sarkizova, S., Shekhar, K., Fletcher, J., Griesbeck, M., Butler, A., Zheng, S., Lazo, S., Jardine, L., Dixon, D., Stephenson, E., Nilsson, E., Grundberg, I., McDonald, D., Filby, A., Li, W., De Jager, P.L., Rozenblatt-Rosen, O., Lane, A.A., Haniffa, M., Regev, A., Hacohen, N., Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science, 356, 2017.
3. See, P., Dutertre, C.A., Chen, J., Gunther, P., McGovern, N., Irac, S.E., Gunawan, M., Beyer, M., Handler, K., Duan, K., Sumatoh, H.R.B., Ruffin, N., Jouve, M., Gea-Mallorqui, E., Hennekam, R.C.M., Lim, T., Yip, C.C., Wen, M., Malleret, B., Low, I., Shadan, N.B., Fen, C.F.S., Tay, A., Lum, J., Zolezzi, F., Larbi, A., Poidinger, M., Chan, J.K.Y., Chen, Q., Renia, L., Haniffa, M., Benaroch, P., Schlitzer, A., Schultze, J.L., Newell, E.W., Ginhoux, F., Mapping the human DC lineage through the integration of high-dimensional techniques. Science, 356, 2017.
4. Murphy, T.L., Grajales-Reyes, G.E., Wu, X., Tussiwand, R., Briseno, C.G., Iwata, A., Kretzer, N.M., Durai, V., Murphy, K.M., Transcriptional control of dendritic cell development. Annu. Rev. Immunol. 34 (2016), 93–119.
5. Knight, S.C., Mertin, J., Stackpoole, A., Clark, J., Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc. Natl. Acad. Sci. U. S. A. 80 (1983), 6032–6035.
6. Ganguly, D., Haak, S., Sisirak, V., Reizis, B., The role of dendritic cells in autoimmunity. Nat. Rev. Immunol. 13 (2013), 566–577.
7. Guery, L., Hugues, S., Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity. Front. Immunol., 4, 2013, 59.
8. Satpathy, A.T., Wu, X., Albring, J.C., Murphy, K.M., Re(de)fining the dendritic cell lineage. Nat. Immunol. 13 (2012), 1145–1154.
9. Onai, N., Kurabayashi, K., Hosoi-Amaike, M., Toyama-Sorimachi, N., Matsushima, K., Inaba, K., Ohteki, T., A clonogenic progenitor with prominent plasmacytoid dendritic cell developmental potential. Immunity 38 (2013), 943–957.
10. Cisse, B., Caton, M.L., Lehner, M., Maeda, T., Scheu, S., Locksley, R., Holmberg, D., Zweier, C., den Hollander, N.S., Kant, S.G., Holter, W., Rauch, A., Zhuang, Y., Reizis, B., Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135 (2008), 37–48.
11. Ghosh, H.S., Cisse, B., Bunin, A., Lewis, K.L., Reizis, B., Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity 33 (2010), 905–916.
12. Schlitzer, A., Loschko, J., Mair, K., Vogelmann, R., Henkel, L., Einwachter, H., Schiemann, M., Niess, J.H., Reindl, W., Krug, A., Identification of CCR9- murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs. Blood 117 (2011), 6562–6570.
13. Schlitzer, A., Heiseke, A.F., Einwachter, H., Reindl, W., Schiemann, M., Manta, C.P., See, P., Niess, J.H., Suter, T., Ginhoux, F., Krug, A.B., Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor. Blood 119 (2012), 6063–6071.
14. Hacker, C., Kirsch, R.D., Ju, X.S., Hieronymus, T., Gust, T.C., Kuhl, C., Jorgas, T., Kurz, S.M., Rose-John, S., Yokota, Y., Zenke, M., Transcriptional profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 4 (2003), 380–386.
15. Spits, H., Couwenberg, F., Bakker, A.Q., Weijer, K., Uittenbogaart, C.H., Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J. Exp. Med. 192 (2000), 1775–1784.
16. Li, H.S., Yang, C.Y., Nallaparaju, K.C., Zhang, H., Liu, Y.J., Goldrath, A.W., Watowich, S.S., The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development. Blood 120 (2012), 4363–4373.
17. Swiecki, M., Colonna, M., The multifaceted biology of plasmacytoid dendritic cells. Nat. Rev. Immunol. 15 (2015), 471–485.
18. Marafioti, T., Paterson, J.C., Ballabio, E., Reichard, K.K., Tedoldi, S., Hollowood, K., Dictor, M., Hansmann, M.L., Pileri, S.A., Dyer, M.J., Sozzani, S., Dikic, I., Shaw, A.S., Petrella, T., Stein, H., Isaacson, P.G., Facchetti, F., Mason, D.Y., Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 111 (2008), 3778–3792.
19. Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., Colonna, M., Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5 (1999), 919–923.
20. Siegal, F.P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P.A., Shah, K., Ho, S., Antonenko, S., Liu, Y.J., The nature of the principal type 1 interferon-producing cells in human blood. Science 284 (1999), 1835–1837.
21. Ito, T., Kanzler, H., Duramad, O., Cao, W., Liu, Y.J., Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 107 (2006), 2423–2431.
22. Pestka, S., Krause, C.D., Walter, M.R., Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202 (2004), 8–32.
23. van Boxel-Dezaire, A.H., Rani, M.R., Stark, G.R., Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25 (2006), 361–372.
24. Uze, G., Schreiber, G., Piehler, J., Pellegrini, S., The receptor of the type I interferon family. Curr. Top. Microbiol. Immunol. 316 (2007), 71–95.
25. Deonarain, R., Chan, D.C., Platanias, L.C., Fish, E.N., Interferon-alpha/beta-receptor interactions: a complex story unfolding. Curr. Pharm. Des. 8 (2002), 2131–2137.
26. Overall, M.L., Chambers, P., Hertzog, P.J., Different interactions of interferon-alpha subtypes at the surface of epithelial and lymphoid cells. J. Interferon Res. 12 (1992), 281–288.
27. Isaacs, A., Lindenmann, J., Virus interference. I. The interferon. Proc. R. Soc. Lond. Ser. B, Biol. Sci. 147 (1957), 258–267.
28. Fitzgerald-Bocarsly, P., Feng, D., The role of type I interferon production by dendritic cells in host defense. Biochimie 89 (2007), 843–855.
29. Hervas-Stubbs, S., Perez-Gracia, J.L., Rouzaut, A., Sanmamed, M.F., Le Bon, A., Melero, I., Direct effects of type I interferons on cells of the immune system. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 17 (2011), 2619–2627.
30. Ferrantini, M., Capone, I., Belardelli, F., Dendritic cells and cytokines in immune rejection of cancer. Cytokine & Growth Factor Rev. 19 (2008), 93–107.
31. Ito, T., Amakawa, R., Inaba, M., Ikehara, S., Inaba, K., Fukuhara, S., Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 166 (2001), 2961–2969.
32. Luft, T., Pang, K.C., Thomas, E., Hertzog, P., Hart, D.N., Trapani, J., Cebon, J., Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161 (1998), 1947–1953.
33. Lapenta, C., Santini, S.M., Spada, M., Donati, S., Urbani, F., Accapezzato, D., Franceschini, D., Andreotti, M., Barnaba, V., Belardelli, F., IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens. Eur. J. Immunol. 36 (2006), 2046–2060.
34. Rizza, P., Moretti, F., Belardelli, F., Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity. Autoimmunity 43 (2010), 204–209.
35. Andoniou, C.E., van Dommelen, S.L., Voigt, V., Andrews, D.M., Brizard, G., Asselin-Paturel, C., Delale, T., Stacey, K.J., Trinchieri, G., Degli-Esposti, M.A., Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 6 (2005), 1011–1019.
36. Rothenfusser, S., Hornung, V., Ayyoub, M., Britsch, S., Towarowski, A., Krug, A., Sarris, A., Lubenow, N., Speiser, D., Endres, S., Hartmann, G., CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro. Blood 103 (2004), 2162–2169.
37. Brinkmann, V., Geiger, T., Alkan, S., Heusser, C.H., Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J. Exp. Med. 178 (1993), 1655–1663.
38. Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F., Tough, D.F., Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14 (2001), 461–470.
39. Bogdan, C., Mattner, J., Schleicher, U., The role of type I interferons in non-viral infections. Immunol. Rev. 202 (2004), 33–48.
40. Bengtsson, A.A., Sturfelt, G., Truedsson, L., Blomberg, J., Alm, G., Vallin, H., Ronnblom, L., Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9 (2000), 664–671.
41. Dikopoulos, N., Bertoletti, A., Kroger, A., Hauser, H., Schirmbeck, R., Reimann, J., Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells. J. Immunol. 174 (2005), 99–109.
42. Howes, A., Taubert, C., Blankley, S., Spink, N., Wu, X., Graham, C.M., Zhao, J., Saraiva, M., Ricciardi-Castagnoli, P., Bancroft, G.J., O'Garra, A., Differential production of type I IFN determines the reciprocal levels of IL-10 and proinflammatory cytokines produced by C57BL/6 and BALB/c macrophages. J. Immunol. 197 (2016), 2838–2853.
43. Crow, M.K., Olferiev, M., Kirou, K.A., Targeting of type I interferon in systemic autoimmune diseases. Transl. Res. J. Lab. Clin. Med. 165 (2015), 296–305.
44. Gresser, I., Belardelli, F., Endogenous type I interferons as a defense against tumors. Cytokine & Growth Factor Rev. 13 (2002), 111–118.
45. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., Lanzavecchia, A., Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31 (2001), 3388–3393.
46. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R.W., Kastelein, R.A., Bazan, F., Liu, Y.J., Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194 (2001), 863–869.
47. Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., Endres, S., Hartmann, G., Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168 (2002), 4531–4537.
48. Kawai, T., Akira, S., The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11 (2010), 373–384.
49. Diebold, S.S., Kaisho, T., Hemmi, H., Akira, S., Reis, C., e Sousa, Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004), 1529–1531.
50. Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., Bauer, S., Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004), 1526–1529.
51. Lund, J.M., Alexopoulou, L., Sato, A., Karow, M., Adams, N.C., Gale, N.W., Iwasaki, A., Flavell, R.A., Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 5598–5603.
52. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., Akira, S., A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000), 740–745.
53. Haas, T., Metzger, J., Schmitz, F., Heit, A., Muller, T., Latz, E., Wagner, H., The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation. Immunity 28 (2008), 315–323.
54. Barton, G.M., Kagan, J.C., Medzhitov, R., Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7 (2006), 49–56.
55. Blasius, A.L., Beutler, B., Intracellular toll-like receptors. Immunity 32 (2010), 305–315.
56. Haller, O., Staeheli, P., Kochs, G., Interferon-induced Mx proteins in antiviral host defense. Biochimie 89 (2007), 812–818.
57. Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C., Taniguchi, T., Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434 (2005), 1035–1040.
58. Guiducci, C., Ott, G., Chan, J.H., Damon, E., Calacsan, C., Matray, T., Lee, K.D., Coffman, R.L., Barrat, F.J., Properties regulating the nature of the plasmacytoid dendritic cell response to toll-like receptor 9 activation. J. Exp. Med. 203 (2006), 1999–2008.
59. Kumagai, Y., Kumar, H., Koyama, S., Kawai, T., Takeuchi, O., Akira, S., Cutting edge: TLR-dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells. J. Immunol. 182 (2009), 3960–3964.
60. Reizis, B., Bunin, A., Ghosh, H.S., Lewis, K.L., Sisirak, V., Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 29 (2011), 163–183.
61. Kwidzinski, E., Bechmann, I., IDO expression in the brain: a double-edged sword. J. Mol. Med. 85 (2007), 1351–1359.
62. Ito, T., Yang, M., Wang, Y.H., Lande, R., Gregorio, J., Perng, O.A., Qin, X.F., Liu, Y.J., Gilliet, M., Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204 (2007), 105–115.
63. Durai, V., Murphy, K.M., Functions of murine dendritic cells. Immunity 45 (2016), 719–736.
64. Jimenez-Dalmaroni, M.J., Gerswhin, M.E., Adamopoulos, I.E., The critical role of toll-like receptors–From microbial recognition to autoimmunity: a comprehensive review. Autoimmun. Rev. 15 (2016), 1–8.
65. Fogg, D.K., Sibon, C., Miled, C., Jung, S., Aucouturier, P., Littman, D.R., Cumano, A., Geissmann, F., A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311 (2006), 83–87.
66. Merad, M., Sathe, P., Helft, J., Miller, J., Mortha, A., The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31 (2013), 563–604.
67. Sichien, D., Lambrecht, B.N., Guilliams, M., Scott, C.L., Development of conventional dendritic cells: from common bone marrow progenitors to multiple subsets in peripheral tissues. Mucosal Immunol. 10 (2017), 831–844.
68. Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S.H., Onai, N., Schraml, B.U., Segura, E., Tussiwand, R., Yona, S., Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat. Rev. Immunol. 14 (2014), 571–578.
69. Guilliams, M., Dutertre, C.A., Scott, C.L., McGovern, N., Sichien, D., Chakarov, S., Van Gassen, S., Chen, J., Poidinger, M., De Prijck, S., Tavernier, S.J., Low, I., Irac, S.E., Mattar, C.N., Sumatoh, H.R., Low, G.H., Chung, T.J., Chan, D.K., Tan, K.K., Hon, T.L., Fossum, E., Bogen, B., Choolani, M., Chan, J.K., Larbi, A., Luche, H., Henri, S., Saeys, Y., Newell, E.W., Lambrecht, B.N., Malissen, B., Ginhoux, F., Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species. Immunity 45 (2016), 669–684.
70. Hildner, K., Edelson, B.T., Purtha, W.E., Diamond, M., Matsushita, H., Kohyama, M., Calderon, B., Schraml, B.U., Unanue, E.R., Diamond, M.S., Schreiber, R.D., Murphy, T.L., Murphy, K.M., Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322 (2008), 1097–1100.
71. Grajales-Reyes, G.E., Iwata, A., Albring, J., Wu, X., Tussiwand, R., Kc, W., Kretzer, N.M., Briseno, C.G., Durai, V., Bagadia, P., Haldar, M., Schonheit, J., Rosenbauer, F., Murphy, T.L., Murphy, K.M., Batf3 maintains autoactivation of Irf8 for commitment of a CD8alpha(+) conventional DC clonogenic progenitor. Nat. Immunol. 16 (2015), 708–717.
72. Sichien, D., Scott, C.L., Martens, L., Vanderkerken, M., Van Gassen, S., Plantinga, M., Joeris, T., De Prijck, S., Vanhoutte, L., Vanheerswynghels, M., Van Isterdael, G., Toussaint, W., Madeira, F.B., Vergote, K., Agace, W.W., Clausen, B.E., Hammad, H., Dalod, M., Saeys, Y., Lambrecht, B.N., Guilliams, M., IRF8 transcription factor controls survival and function of terminally differentiated conventional and plasmacytoid dendritic cells, respectively. Immunity 45 (2016), 626–640.
73. Bajana, S., Roach, K., Turner, S., Paul, J., Kovats, S., IRF4 promotes cutaneous dendritic cell migration to lymph nodes during homeostasis and inflammation. J. Immunol. 189 (2012), 3368–3377.
74. Persson, E.K., Uronen-Hansson, H., Semmrich, M., Rivollier, A., Hagerbrand, K., Marsal, J., Gudjonsson, S., Hakansson, U., Reizis, B., Kotarsky, K., Agace, W.W., IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 38 (2013), 958–969.
75. Schlitzer, A., McGovern, N., Teo, P., Zelante, T., Atarashi, K., Low, D., Ho, A.W., See, P., Shin, A., Wasan, P.S., Hoeffel, G., Malleret, B., Heiseke, A., Chew, S., Jardine, L., Purvis, H.A., Hilkens, C.M., Tam, J., Poidinger, M., Stanley, E.R., Krug, A.B., Renia, L., Sivasankar, B., Ng, L.G., Collin, M., Ricciardi-Castagnoli, P., Honda, K., Haniffa, M., Ginhoux, F., IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38 (2013), 970–983.
76. Haniffa, M., Collin, M., Ginhoux, F., Ontogeny and functional specialization of dendritic cells in human and mouse. Adv. Immunol. 120 (2013), 1–49.
77. Jongbloed, S.L., Kassianos, A.J., McDonald, K.J., Clark, G.J., Ju, X., Angel, C.E., Chen, C.J., Dunbar, P.R., Wadley, R.B., Jeet, V., Vulink, A.J., Hart, D.N., Radford, K.J., Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 207 (2010), 1247–1260.
78. Nizzoli, G., Krietsch, J., Weick, A., Steinfelder, S., Facciotti, F., Gruarin, P., Bianco, A., Steckel, B., Moro, M., Crosti, M., Romagnani, C., Stolzel, K., Torretta, S., Pignataro, L., Scheibenbogen, C., Neddermann, P., De Francesco, R., Abrignani, S., Geginat, J., Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Blood 122 (2013), 932–942.
79. Hammad, H., Plantinga, M., Deswarte, K., Pouliot, P., Willart, M.A., Kool, M., Muskens, F., Lambrecht, B.N., Inflammatory dendritic cells–not basophils–are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J. Exp. Med. 207 (2010), 2097–2111.
80. Campbell, I.K., van Nieuwenhuijze, A., Segura, E., O'Donnell, K., Coghill, E., Hommel, M., Gerondakis, S., Villadangos, J.A., Wicks, I.P., Differentiation of inflammatory dendritic cells is mediated by NF-kappaB1-dependent GM-CSF production in CD4 T cells. J. Immunol. 186 (2011), 5468–5477.
81. Segura, E., Amigorena, S., Inflammatory dendritic cells in mice and humans. Trends Immunol. 34 (2013), 440–445.
82. Segura, E., Touzot, M., Bohineust, A., Cappuccio, A., Chiocchia, G., Hosmalin, A., Dalod, M., Soumelis, V., Amigorena, S., Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 38 (2013), 336–348.
83. Mashayekhi, M., Sandau, M.M., Dunay, I.R., Frickel, E.M., Khan, A., Goldszmid, R.S., Sher, A., Ploegh, H.L., Murphy, T.L., Sibley, L.D., Murphy, K.M., CD8alpha(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 35 (2011), 249–259.
84. Satpathy, A.T., Briseno, C.G., Lee, J.S., Ng, D., Manieri, N.A., Kc, W., Wu, X., Thomas, S.R., Lee, W.L., Turkoz, M., McDonald, K.G., Meredith, M.M., Song, C., Guidos, C.J., Newberry, R.D., Ouyang, W., Murphy, T.L., Stappenbeck, T.S., Gommerman, J.L., Nussenzweig, M.C., Colonna, M., Kopan, R., Murphy, K.M., Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat. Immunol. 14 (2013), 937–948.
85. Briseno, C.G., Murphy, T.L., Murphy, K.M., Complementary diversification of dendritic cells and innate lymphoid cells. Curr. Opin. Immunol. 29 (2014), 69–78.
86. Tussiwand, R., Everts, B., Grajales-Reyes, G.E., Kretzer, N.M., Iwata, A., Bagaitkar, J., Wu, X., Wong, R., Anderson, D.A., Murphy, T.L., Pearce, E.J., Murphy, K.M., Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses. Immunity 42 (2015), 916–928.
87. Swiecki, M., Gilfillan, S., Vermi, W., Wang, Y., Colonna, M., Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 33 (2010), 955–966.
88. Takagi, H., Fukaya, T., Eizumi, K., Sato, Y., Sato, K., Shibazaki, A., Otsuka, H., Hijikata, A., Watanabe, T., Ohara, O., Kaisho, T., Malissen, B., Sato, K., Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity 35 (2011), 958–971.
89. Cervantes-Barragan, L., Lewis, K.L., Firner, S., Thiel, V., Hugues, S., Reith, W., Ludewig, B., Reizis, B., Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 3012–3017.
90. Swiecki, M., Wang, Y., Riboldi, E., Kim, A.H., Dzutsev, A., Gilfillan, S., Vermi, W., Ruedl, C., Trinchieri, G., Colonna, M., Cell depletion in mice that express diphtheria toxin receptor under the control of SiglecH encompasses more than plasmacytoid dendritic cells. J. Immunol. 192 (2014), 4409–4416.
91. Bar-On, L., Birnberg, T., Lewis, K.L., Edelson, B.T., Bruder, D., Hildner, K., Buer, J., Murphy, K.M., Reizis, B., Jung, S., CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 14745–14750.
92. Jung, S., Unutmaz, D., Wong, P., Sano, G., De los Santos, K., Sparwasser, T., Wu, S., Vuthoori, S., Ko, K., Zavala, F., Pamer, E.G., D.R. Littman and R.A. Lang, in vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17 (2002), 211–220.
93. Postigo, A.A., Corbi, A.L., Sanchez-Madrid, F., de Landazuri, M.O., Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18. J. Exp. Med. 174 (1991), 1313–1322.
94. Guilliams, M., De Kleer, I., Henri, S., Post, S., Vanhoutte, L., De Prijck, S., Deswarte, K., Malissen, B., Hammad, H., Lambrecht, B.N., Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 210 (2013), 1977–1992.
95. You, Q., Holt, M., Yin, H., Li, G., Hu, C.J., Ju, C., Role of hepatic resident and infiltrating macrophages in liver repair after acute injury. Biochem. Pharmacol. 86 (2013), 836–843.
96. Meredith, M.M., Liu, K., Darrasse-Jeze, G., Kamphorst, A.O., Schreiber, H.A., Guermonprez, P., Idoyaga, J., Cheong, C., Yao, K.H., Niec, R.E., Nussenzweig, M.C., Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J. Exp. Med. 209 (2012), 1153–1165.
97. Loschko, J., Rieke, G.J., Schreiber, H.A., Meredith, M.M., Yao, K.H., Guermonprez, P., Nussenzweig, M.C., Inducible targeting of cDCs and their subsets in vivo. J. Immunol. Methods 434 (2016), 32–38.
98. Sozzani, S., Vermi, W., Del Prete, A., Facchetti, F., Trafficking properties of plasmacytoid dendritic cells in health and disease. Trends Immunol. 31 (2010), 270–277.
99. Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P., Jahnsen, F.L., Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159 (2001), 237–243.
100. Lande, R., Giacomini, E., Serafini, B., Rosicarelli, B., Sebastiani, G.D., Minisola, G., Tarantino, U., Riccieri, V., Valesini, G., Coccia, E.M., Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J. Immunol. 173 (2004), 2815–2824.
101. Nestle, F.O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G., Liu, Y.J., Gilliet, M., Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J. Exp. Med. 202 (2005), 135–143.
102. Penna, G., Sozzani, S., Adorini, L., Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 167 (2001), 1862–1866.
103. Krug, A., Uppaluri, R., Facchetti, F., Dorner, B.G., Sheehan, K.C., Schreiber, R.D., Cella, M., Colonna, M., IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J. Immunol. 169 (2002), 6079–6083.
104. Vanbervliet, B., Bendriss-Vermare, N., Massacrier, C., Homey, B., de Bouteiller, O., Briere, F., Trinchieri, G., Caux, C., The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J. Exp. Med. 198 (2003), 823–830.
105. Kohrgruber, N., Groger, M., Meraner, P., Kriehuber, E., Petzelbauer, P., Brandt, S., Stingl, G., Rot, A., Maurer, D., Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. J. Immunol. 173 (2004), 6592–6602.
106. Cicinnati, V.R., Kang, J., Sotiropoulos, G.C., Hilgard, P., Frilling, A., Broelsch, C.E., Gerken, G., Beckebaum, S., Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon. J. General Virol. 89 (2008), 1243–1253.
107. Cicinnati, V.R., Hou, J., Lindemann, M., Horn, P.A., Sotiropoulos, G.C., Paul, A., Gerken, G., Beckebaum, S., Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells. Transplantation 88 (2009), 504–513.
108. Schnurr, M., Toy, T., Shin, A., Hartmann, G., Rothenfusser, S., Soellner, J., Davis, I.D., Cebon, J., Maraskovsky, E., Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells. Blood 103 (2004), 1391–1397.
109. Devosse, T., Guillabert, A., D'Haene, N., Berton, A., De Nadai, P., Noel, S., Brait, M., Franssen, J.D., Sozzani, S., Salmon, I., Parmentier, M., Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils. J. Immunol. 182 (2009), 4974–4984.
110. Gutzmer, R., Kother, B., Zwirner, J., Dijkstra, D., Purwar, R., Wittmann, M., Werfel, T., Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a. J. Investig. Dermatol. 126 (2006), 2422–2429.
111. Kaser, A., Kaser, S., Kaneider, N.C., Enrich, B., Wiedermann, C.J., Tilg, H., Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression. Blood 103 (2004), 648–655.
112. Vermi, W., Riboldi, E., Wittamer, V., Gentili, F., Luini, W., Marrelli, S., Vecchi, A., Franssen, J.D., Communi, D., Massardi, L., Sironi, M., Mantovani, A., Parmentier, M., Facchetti, F., Sozzani, S., Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 201 (2005), 509–515.
113. Zabel, B.A., Nakae, S., Zuniga, L., Kim, J.Y., Ohyama, T., Alt, C., Pan, J., Suto, H., Soler, D., Allen, S.J., Handel, T.M., Song, C.H., Galli, S.J., Butcher, E.C., Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J. Exp. Med. 205 (2008), 2207–2220.
114. Albanesi, C., Scarponi, C., Pallotta, S., Daniele, R., Bosisio, D., Madonna, S., Fortugno, P., Gonzalvo-Feo, S., Franssen, J.D., Parmentier, M., De Pita, O., Girolomoni, G., Sozzani, S., Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med. 206 (2009), 249–258.
115. Parolini, S., Santoro, A., Marcenaro, E., Luini, W., Massardi, L., Facchetti, F., Communi, D., Parmentier, M., Majorana, A., Sironi, M., Tabellini, G., Moretta, A., Sozzani, S., The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109 (2007), 3625–3632.
116. Graham, K.L., Zhang, J.V., Lewen, S., Burke, T.M., Dang, T., Zoudilova, M., Sobel, R.A., Butcher, E.C., Zabel, B.A., A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease. PloS One, 9, 2014, e112925.
117. Duraes, F.V., Lippens, C., Steinbach, K., Dubrot, J., Brighouse, D., Bendriss-Vermare, N., Issazadeh-Navikas, S., Merkler, D., Hugues, S., pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation. J. Autoimmun. 67 (2016), 8–18.
118. Worbs, T., Hammerschmidt, S.I., Forster, R., Dendritic cell migration in health and disease. Nat. Rev. Immunol. 17 (2017), 30–48.
119. Gill, M.A., Blanco, P., Arce, E., Pascual, V., Banchereau, J., Palucka, A.K., Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum. Immunol. 63 (2002), 1172–1180.
120. Migita, K., Miyashita, T., Maeda, Y., Kimura, H., Nakamura, M., Yatsuhashi, H., Ishibashi, H., Eguchi, K., Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus. Clin. Exp. Immunol. 142 (2005), 84–91.
121. Jin, O., Kavikondala, S., Sun, L., Fu, R., Mok, M.Y., Chan, A., Yeung, J., Lau, C.S., Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression. Lupus 17 (2008), 654–662.
122. Jongbloed, S.L., Lebre, M.C., Fraser, A.R., Gracie, J.A., Sturrock, R.D., Tak, P.P., McInnes, I.B., Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res. Ther., 8, 2006, R15.
123. Power, C.A., Church, D.J., Meyer, A., Alouani, S., Proudfoot, A.E., Clark-Lewis, I., Sozzani, S., Mantovani, A., Wells, T.N., Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells. J. Exp. Med. 186 (1997), 825–835.
124. Page, G., Miossec, P., Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression. J. Pathol. 204 (2004), 28–38.
125. Page, G., Chevrel, G., Miossec, P., Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheum. 50 (2004), 199–208.
126. Page, G., Lebecque, S., Miossec, P., Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J. Immunol. 168 (2002), 5333–5341.
127. Noort, A.R., van Zoest, K.P., van Baarsen, L.G., Maracle, C.X., Helder, B., Papazian, N., Romera-Hernandez, M., Tak, P.P., Cupedo, T., Tas, S.W., Tertiary lymphoid structures in rheumatoid arthritis: NF-kappaB-Inducing kinase-positive endothelial cells as central players. Am. J. Pathol. 185 (2015), 1935–1943.
128. Rodriguez-Pla, A., Patel, P., Maecker, H.T., Rossello-Urgell, J., Baldwin, N., Bennett, L., Cantrell, V., Baisch, J., Punaro, M., Gotte, A., Nassi, L., Wright, T., Palucka, A.K., Banchereau, J., Pascual, V., IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes. J. Immunol. 192 (2014), 5586–5598.
129. Clatworthy, M.R., Aronin, C.E., Mathews, R.J., Morgan, N.Y., Smith, K.G., Germain, R.N., Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes. Nat. Med. 20 (2014), 1458–1463.
130. Bondue, B., Wittamer, V., Parmentier, M., Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine & Growth Factor Rev. 22 (2011), 331–338.
131. Kaneko, K., Miyabe, Y., Takayasu, A., Fukuda, S., Miyabe, C., Ebisawa, M., Yokoyama, W., Watanabe, K., Imai, T., Muramoto, K., Terashima, Y., Sugihara, T., Matsushima, K., Miyasaka, N., Nanki, T., Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis. Arthritis Res. Ther., 13, 2011, R158.
132. Eisinger, K., Bauer, S., Schaffler, A., Walter, R., Neumann, E., Buechler, C., Muller-Ladner, U., Frommer, K.W., Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Exp. Mol. Pathol. 92 (2012), 90–96.
133. De Palma, G., Castellano, G., Del Prete, A., Sozzani, S., Fiore, N., Loverre, A., Parmentier, M., Gesualdo, L., Grandaliano, G., Schena, F.P., The possible role of ChemR23/Chemerin axis in the recruitment of dendritic cells in lupus nephritis. Kidney Int. 79 (2011), 1228–1235.
134. Sozzani, S., Bosisio, D., Scarsi, M., Tincani, A., Type I interferons in systemic autoimmunity. Autoimmunity 43 (2010), 196–203.
135. Gilliet, M., Cao, W., Liu, Y.J., Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8 (2008), 594–606.
136. Pisetsky, D.S., Fairhurst, A.M., The origin of extracellular DNA during the clearance of dead and dying cells. Autoimmunity 40 (2007), 281–284.
137. Yang, H., Biermann, M.H., Brauner, J.M., Liu, Y., Zhao, Y., Herrmann, M., New insights into neutrophil extracellular traps: mechanisms of formation and role in inflammation. Front. Immunol., 7, 2016, 302.
138. Smith, C.K., Kaplan, M.J., The role of neutrophils in the pathogenesis of systemic lupus erythematosus. Curr. Opin. Rheumatol. 27 (2015), 448–453.
139. Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.H., Homey, B., Cao, W., Wang, Y.H., Su, B., Nestle, F.O., Zal, T., Mellman, I., Schroder, J.M., Liu, Y.J., Gilliet, M., Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449 (2007), 564–569.
140. Lande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gregorio, J., Meller, S., Chamilos, G., Sebasigari, R., Riccieri, V., Bassett, R., Amuro, H., Fukuhara, S., Ito, T., Liu, Y.J., Gilliet, M., Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med., 3, 2011, 73ra19.
141. Lande, R., Chamilos, G., Ganguly, D., Demaria, O., Frasca, L., Durr, S., Conrad, C., Schroder, J., Gilliet, M., Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA. Eur. J. Immunol. 45 (2015), 203–213.
142. Sandgren, S., Wittrup, A., Cheng, F., Jonsson, M., Eklund, E., Busch, S., Belting, M., The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J. Biol. Chem. 279 (2004), 17951–17956.
143. Tian, J., Avalos, A.M., Mao, S.Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., Hua, J., An, L.L., Audoly, L., La Rosa, G., Bierhaus, A., Naworth, P., Marshak-Rothstein, A., Crow, M.K., Fitzgerald, K.A., Latz, E., Kiener, P.A., Coyle, A.J., Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8 (2007), 487–496.
144. Diana, J., Simoni, Y., Furio, L., Beaudoin, L., Agerberth, B., Barrat, F., Lehuen, A., Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat. Med. 19 (2013), 65–73.
145. Lovgren, T., Eloranta, M.L., Bave, U., Alm, G.V., Ronnblom, L., Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 50 (2004), 1861–1872.
146. Barrat, F.J., Meeker, T., Gregorio, J., Chan, J.H., Uematsu, S., Akira, S., Chang, B., Duramad, O., Coffman, R.L., Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202 (2005), 1131–1139.
147. Means, T.K., Latz, E., Hayashi, F., Murali, M.R., Golenbock, D.T., Luster, A.D., Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Investig. 115 (2005), 407–417.
148. Henault, J., Martinez, J., Riggs, J.M., Tian, J., Mehta, P., Clarke, L., Sasai, M., Latz, E., Brinkmann, M.M., Iwasaki, A., Coyle, A.J., Kolbeck, R., Green, D.R., Sanjuan, M.A., Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes. Immunity 37 (2012), 986–997.
149. Chan, V.S., Nie, Y.J., Shen, N., Yan, S., Mok, M.Y., Lau, C.S., Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmun. Rev. 11 (2012), 890–897.
150. Bave, U., Nordmark, G., Lovgren, T., Ronnelid, J., Cajander, S., Eloranta, M.L., Alm, G.V., Ronnblom, L., Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum. 52 (2005), 1185–1195.
151. Eloranta, M.L., Barbasso Helmers, S., Ulfgren, A.K., Ronnblom, L., Alm, G.V., Lundberg, I.E., A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies. Arthritis Rheum. 56 (2007), 3112–3124.
152. Eloranta, M.L., Franck-Larsson, K., Lovgren, T., Kalamajski, S., Ronnblom, A., Rubin, K., Alm, G.V., Ronnblom, L., Type I interferon system activation and association with disease manifestations in systemic sclerosis. Ann. Rheum. Dis. 69 (2010), 1396–1402.
153. Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., Homey, B., Barrat, F.J., Zal, T., Gilliet, M., Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 206 (2009), 1983–1994.
154. Vollmer, J., Tluk, S., Schmitz, C., Hamm, S., Jurk, M., Forsbach, A., Akira, S., Kelly, K.M., Reeves, W.H., Bauer, S., Krieg, A.M., Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 202 (2005), 1575–1585.
155. Christensen, S.R., Shlomchik, M.J., Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin. Immunol. 19 (2007), 11–23.
156. Turchinovich, A., Samatov, T.R., Tonevitsky, A.G., Burwinkel, B., Circulating miRNAs: cell-cell communication function?. Front. Genet., 4, 2013, 119.
157. Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., Lovat, F., Fadda, P., Mao, C., Nuovo, G.J., Zanesi, N., Crawford, M., Ozer, G.H., Wernicke, D., Alder, H., Caligiuri, M.A., Nana-Sinkam, P., Perrotti, D., Croce, C.M., MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), E2110–E2116.
158. Lehmann, S.M., Kruger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., Trimbuch, T., Eom, G., Hinz, M., Kaul, D., Habbel, P., Kalin, R., Franzoni, E., Rybak, A., Nguyen, D., Veh, R., Ninnemann, O., Peters, O., Nitsch, R., Heppner, F.L., Golenbock, D., Schott, E., Ploegh, H.L., Wulczyn, F.G., Lehnardt, S., An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 15 (2012), 827–835.
159. Chen, J.Q., Papp, G., Szodoray, P., Zeher, M., The role of microRNAs in the pathogenesis of autoimmune diseases. Autoimmun. Rev. 15 (2016), 1171–1180.
160. Wang, M.J., Xu, Y.Y., Huang, R.Y., Chen, X.M., Chen, H.M., Han, L., Yan, Y.H., Lu, C.J., Role of an imbalanced miRNAs axis in pathogenesis of psoriasis: novel perspectives based on review of the literature. Oncotarget 8 (2017), 5498–5507.
161. Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mule, J., Kerr, W.G., Jove, R., Pardoll, D., Yu, H., Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat. Med. 11 (2005), 1314–1321.
162. Hartgring, S.A., Willis, C.R., Dean, C.E. Jr., Broere, F., van Eden, W., Bijlsma, J.W., Lafeber, F.P., van Roon, J.A., Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis. Arthritis Rheum. 63 (2011), 1878–1887.
163. Moret, F.M., Hack, C.E., van der Wurff-Jacobs, K.M., Radstake, T.R., Lafeber, F.P., van Roon, J.A., Thymic stromal lymphopoietin, a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c+ myeloid dendritic cells to attract and stimulate T cells. Arthritis Rheumatol. 66 (2014), 1176–1184.
164. van Roon, J.A., Verweij, M.C., Wijk, M.W., Jacobs, K.M., Bijlsma, J.W., Lafeber, F.P., Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages. Arthritis Rheum. 52 (2005), 1700–1710.
165. Moret, F.M., van der Wurff-Jacobs, K.M., Bijlsma, J.W., Lafeber, F.P., van Roon, J.A., Synovial T cell hyporesponsiveness to myeloid dendritic cells is reversed by preventing PD-1/PD-L1 interactions. Arthritis Res. Ther., 16, 2014, 497.
166. Reynolds, G., Gibbon, J.R., Pratt, A.G., Wood, M.J., Coady, D., Raftery, G., Lorenzi, A.R., Gray, A., Filer, A., Buckley, C.D., Haniffa, M.A., Isaacs, J.D., Hilkens, C.M., Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis. Ann. Rheum. Dis. 75 (2016), 899–907.
167. Lee, L.F., Xu, B., Michie, S.A., Beilhack, G.F., Warganich, T., Turley, S., McDevitt, H.O., The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 15995–16000.
168. Kim, H.S., Han, M.S., Chung, K.W., Kim, S., Kim, E., Kim, M.J., Jang, E., Lee, H.A., Youn, J., Akira, S., Lee, M.S., Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity 27 (2007), 321–333.
169. Desnues, B., Macedo, A.B., Roussel-Queval, A., Bonnardel, J., Henri, S., Demaria, O., Alexopoulou, L., TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 1497–1502.
170. Teichmann, L.L., Schenten, D., Medzhitov, R., Kashgarian, M., Shlomchik, M.J., Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity 38 (2013), 528–540.
171. Lamagna, C., Scapini, P., van Ziffle, J.A., DeFranco, A.L., Lowell, C.A., Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), E3311–E3320.
172. Tada, Y., Kondo, S., Aoki, S., Koarada, S., Inoue, H., Suematsu, R., Ohta, A., Mak, T.W., Nagasawa, K., Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Arthritis Rheum. 63 (2011), 738–748.
173. Kool, M., van Loo, G., Waelput, W., De Prijck, S., Muskens, F., Sze, M., van Praet, J., Branco-Madeira, F., Janssens, S., Reizis, B., Elewaut, D., Beyaert, R., Hammad, H., Lambrecht, B.N., The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity 35 (2011), 82–96.
174. Chen, M., Huang, L., Wang, J., Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity. Blood 109 (2007), 4360–4367.
175. Celhar, T., Hopkins, R., Thornhill, S.I., De Magalhaes, R., Hwang, S.H., Lee, H.Y., Yasuga, H., Jones, L.A., Casco, J., Lee, B., Thamboo, T.P., Zhou, X.J., Poidinger, M., Connolly, J.E., Wakeland, E.K., Fairhurst, A.M., RNA sensing by conventional dendritic cells is central to the development of lupus nephritis. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E6195–E6204.
176. Jensen, M.A., Patterson, K.C., Kumar, A.A., Kumabe, M., Franek, B.S., Niewold, T.B., Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients. Ann. Rheum. Dis. 72 (2013), 596–601.
177. Xie, H., Hua, C., Sun, L., Zhao, X., Fan, H., Dou, H., Hou, Y., 17beta-estradiol induces CD40 expression in dendritic cells via MAPK signaling pathways in a minichromosome maintenance protein 6-dependent manner. Arthritis Rheum. 63 (2011), 2425–2435.
178. Csomor, E., Bajtay, Z., Sandor, N., Kristof, K., Arlaud, G.J., Thiel, S., Erdei, A., Complement protein C1q induces maturation of human dendritic cells. Mol. Immunol. 44 (2007), 3389–3397.
179. Teh, B.K., Yeo, J.G., Chern, L.M., Lu, J., C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation. Mol. Immunol. 48 (2011), 1128–1138.
180. Stranges, P.B., Watson, J., Cooper, C.J., Choisy-Rossi, C.M., Stonebraker, A.C., Beighton, R.A., Hartig, H., Sundberg, J.P., Servick, S., Kaufmann, G., Fink, P.J., Chervonsky, A.V., Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 26 (2007), 629–641.
181. Chen, M., Felix, K., Wang, J., Immune regulation through mitochondrion-dependent dendritic cell death induced by T regulatory cells. J. Immunol. 187 (2011), 5684–5692.
182. Ramirez-Ortiz, Z.G., Pendergraft, W.F. 3rd, Prasad, A., Byrne, M.H., Iram, T., Blanchette, C.J., Luster, A.D., Hacohen, N., El Khoury, J., Means, T.K., The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity. Nat. Immunol. 14 (2013), 917–926.
183. Wohn, C., Ober-Blobaum, J.L., Haak, S., Pantelyushin, S., Cheong, C., Zahner, S.P., Onderwater, S., Kant, M., Weighardt, H., Holzmann, B., Reizis, B., Becher, B., Prens, E.P., Clausen, B.E., Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 10723–10728.
184. Decker, P., Singh-Jasuja, H., Haager, S., Kotter, I., Rammensee, H.G., Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. J. Immunol. 174 (2005), 3326–3334.
185. Kis-Toth, K., Szanto, A., Thai, T.H., Tsokos, G.C., Cytosolic DNA-activated human dendritic cells are potent activators of the adaptive immune response. J. Immunol. 187 (2011), 1222–1234.
186. Eloranta, M.L., Ronnblom, L., Cause and consequences of the activated type I interferon system in SLE. J. Mol. Med. 94 (2016), 1103–1110.
187. Ytterberg, S.R., Huard, T.K., Schnitzer, T.J., Effects of serum from patients with system lupus erythematosus on leukocyte cytotoxicity: modulation of NK activity and ADCC. J. Rheumatol. 10 (1983), 906–912.
188. Blomberg, S., Eloranta, M.L., Cederblad, B., Nordlin, K., Alm, G.V., Ronnblom, L., Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus 10 (2001), 484–490.
189. Bennett, L., Palucka, A.K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., Pascual, V., Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197 (2003), 711–723.
190. Hjelmervik, T.O., Petersen, K., Jonassen, I., Jonsson, R., Bolstad, A.I., Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum. 52 (2005), 1534–1544.
191. Baechler, E.C., Batliwalla, F.M., Reed, A.M., Peterson, E.J., Gaffney, P.M., Moser, K.L., Gregersen, P.K., Behrens, T.W., Gene expression profiling in human autoimmunity. Immunol. Rev. 210 (2006), 120–137.
192. Higgs, B.W., Liu, Z., White, B., Zhu, W., White, W.I., Morehouse, C., Brohawn, P., Kiener, P.A., Richman, L., Fiorentino, D., Greenberg, S.A., Jallal, B., Yao, Y., Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann. Rheum. Dis. 70 (2011), 2029–2036.
193. Schmid, P., Itin, P., Cox, D., McMaster, G.K., Horisberger, M.A., The type I interferon system is locally activated in psoriatic lesions. J. Interferon Res. 14 (1994), 229–234.
194. Yao, Y., Richman, L., Morehouse, C., de los Reyes, M., Higgs, B.W., Boutrin, A., White, B., Coyle, A., Krueger, J., Kiener, P.A., Jallal, B., Type I interferon: potential therapeutic target for psoriasis?. PloS One, 3, 2008, e2737.
195. Joo, H., Coquery, C., Xue, Y., Gayet, I., Dillon, S.R., Punaro, M., Zurawski, G., Banchereau, J., Pascual, V., Oh, S., Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation. J. Exp. Med. 209 (2012), 1335–1348.
196. Li, Q., Xu, B., Michie, S.A., Rubins, K.H., Schreriber, R.D., McDevitt, H.O., Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 12439–12444.
197. Wollenberg, A., Wagner, M., Gunther, S., Towarowski, A., Tuma, E., Moderer, M., Rothenfusser, S., Wetzel, S., Endres, S., Hartmann, G., Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J. Investig. Dermatol. 119 (2002), 1096–1102.
198. Dzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Gunther, G., Johnston, I., Lanzavecchia, A., Nagasaka, T., Okada, T., Vermi, W., Winkels, G., Yamamoto, T., Zysk, M., Yamaguchi, Y., Schmitz, J., BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194 (2001), 1823–1834.
199. Sobel, D.O., Ahvazi, B., Alpha-interferon inhibits the development of diabetes in NOD mice. Diabetes 47 (1998), 1867–1872.
200. Sobel, D.O., Creswell, K., Yoon, J.W., Holterman, D., Alpha interferon administration paradoxically inhibits the development of diabetes in BB rats. Life Sci. 62 (1998), 1293–1302.
201. Tanaka-Kataoka, M., Kunikata, T., Takayama, S., Iwaki, K., Fujii, M., Ohashi, K., Ikeda, M., Kurimoto, M., Oral use of interferon-alpha delays the onset of insulin-dependent diabetes mellitus in nonobese diabetes mice. J. Interferon & Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res. 19 (1999), 877–879.
202. Brod, S.A., Ingested type I interferon: state of the art as treatment for autoimmunity. Exp. Biol. Med. 227 (2002), 981–988.
203. Macritchie, N., Grassia, G., Sabir, S.R., Maddaluno, M., Welsh, P., Sattar, N., Ialenti, A., Kurowska-Stolarska, M., McInnes, I.B., Brewer, J.M., Garside, P., Maffia, P., Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice. Arterioscler., Thromb., Vasc. Biol. 32 (2012), 2569–2579.
204. Baccala, R., Gonzalez-Quintial, R., Blasius, A.L., Rimann, I., Ozato, K., Kono, D.H., Beutler, B., Theofilopoulos, A.N., Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 2940–2945.
205. Sisirak, V., Ganguly, D., Lewis, K.L., Couillault, C., Tanaka, L., Bolland, S., D'Agati, V., Elkon, K.B., Reizis, B., Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J. Exp. Med. 211 (2014), 1969–1976.
206. Rowland, S.L., Riggs, J.M., Gilfillan, S., Bugatti, M., Vermi, W., Kolbeck, R., Unanue, E.R., Sanjuan, M.A., Colonna, M., Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. J. Exp. Med. 211 (2014), 1977–1991.
207. Goodkin, D.E., Interferon beta treatment for multiple sclerosis: persisting questions. Mult. Scler. 1 (1996), 321–324.
208. Annibali, V., Mechelli, R., Romano, S., Buscarinu, M.C., Fornasiero, A., Umeton, R., Ricigliano, V.A., Orzi, F., Coccia, E.M., Salvetti, M., Ristori, G., IFN-beta and multiple sclerosis: from etiology to therapy and back. Cytokine & Growth Factor Rev. 26 (2015), 221–228.
209. Prinz, M., Schmidt, H., Mildner, A., Knobeloch, K.P., Hanisch, U.K., Raasch, J., Merkler, D., Detje, C., Gutcher, I., Mages, J., Lang, R., Martin, R., Gold, R., Becher, B., Bruck, W., Kalinke, U., Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28 (2008), 675–686.
210. von Glehn, F., Santos, L.M., Balashov, K.E., Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis. Immunotherapy 4 (2012), 1053–1061.
211. Isaksson, M., Ardesjo, B., Ronnblom, L., Kampe, O., Lassmann, H., Eloranta, M.L., Lobell, A., Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE. Eur. J. Immunol. 39 (2009), 2925–2935.
212. Bailey-Bucktrout, S.L., Caulkins, S.C., Goings, G., Fischer, J.A., Dzionek, A., Miller, S.D., Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J. Immunol. 180 (2008), 6457–6461.
213. Bailey, S.L., Schreiner, B., McMahon, E.J., Miller, S.D., CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat. Immunol. 8 (2007), 172–180.
214. Irla, M., Kupfer, N., Suter, T., Lissilaa, R., Benkhoucha, M., Skupsky, J., Lalive, P.H., Fontana, A., Reith, W., Hugues, S., MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity. J. Exp. Med. 207 (2010), 1891–1905.
215. Lebre, M.C., Jongbloed, S.L., Tas, S.W., Smeets, T.J., McInnes, I.B., Tak, P.P., Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles. Am. J. Pathol. 172 (2008), 940–950.
216. Tournadre, A., Lenief, V., Eljaafari, A., Miossec, P., Immature muscle precursors are a source of interferon-beta in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation. Arthritis Rheum. 64 (2012), 533–541.
217. Moret, F.M., Hack, C.E., van der Wurff-Jacobs, K.M., de Jager, W., Radstake, T.R., Lafeber, F.P., van Roon, J.A., Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity. Arthritis Res. Ther., 15, 2013, R155.
218. Takayanagi, H., Osteoimmunology and the effects of the immune system on bone. Nat. Rev. Rheumatol. 5 (2009), 667–676.
219. Hot, A., Miossec, P., Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann. Rheum. Dis. 70 (2011), 727–732.
220. Rivollier, A., Mazzorana, M., Tebib, J., Piperno, M., Aitsiselmi, T., Rabourdin-Combe, C., Jurdic, P., Servet-Delprat, C., Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104 (2004), 4029–4037.
221. Kim, T.G., Kim, D.S., Kim, H.P., Lee, M.G., The pathophysiological role of dendritic cell subsets in psoriasis. BMB Rep. 47 (2014), 60–68.
222. Lowes, M.A., Chamian, F., Abello, M.V., Fuentes-Duculan, J., Lin, S.L., Nussbaum, R., Novitskaya, I., Carbonaro, H., Cardinale, I., Kikuchi, T., Gilleaudeau, P., Sullivan-Whalen, M., Wittkowski, K.M., Papp, K., Garovoy, M., Dummer, W., Steinman, R.M., Krueger, J.G., Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 19057–19062.
223. Greter, M., Heppner, F.L., Lemos, M.P., Odermatt, B.M., Goebels, N., Laufer, T., Noelle, R.J., Becher, B., Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11 (2005), 328–334.
224. Poppensieker, K., Otte, D.M., Schurmann, B., Limmer, A., Dresing, P., Drews, E., Schumak, B., Klotz, L., Raasch, J., Mildner, A., Waisman, A., Scheu, S., Knolle, P., Forster, I., Prinz, M., Maier, W., Zimmer, A., Alferink, J., CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 3897–3902.
225. Codarri, L., Gyulveszi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., Becher, B., RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12 (2011), 560–567.
226. El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.X., Dittel, B.N., Rostami, A., The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12 (2011), 568–575.
227. Zaba, L.C., Smith, G.P., Sanchez, M., Prystowsky, S.D., Dendritic cells in the pathogenesis of sarcoidosis. Am. J. Respir. Cell Mol. Biol. 42 (2010), 32–39.
228. Lommatzsch, M., Bratke, K., Bier, A., Julius, P., Kuepper, M., Luttmann, W., Virchow, J.C., Airway dendritic cell phenotypes in inflammatory diseases of the human lung. Eur. Respir. J. 30 (2007), 878–886.
229. Shigehara, K., Shijubo, N., Ohmichi, M., Takahashi, R., Kon, S., Okamura, H., Kurimoto, M., Hiraga, Y., Tatsuno, T., Abe, S., Sato, N., IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J. Immunol. 166 (2001), 642–649.
230. Maloy, K.J., Powrie, F., Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474 (2011), 298–306.
231. Benedetti, G., Miossec, P., Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. Eur. J. Immunol. 44 (2014), 339–347.
232. Prevosto, C., Goodall, J.C., Hill Gaston, J.S., Cytokine secretion by pathogen recognition receptor-stimulated dendritic cells in rheumatoid arthritis and ankylosing spondylitis. J. Rheumatol. 39 (2012), 1918–1928.
233. Gravano, D.M., Hoyer, K.K., Promotion and prevention of autoimmune disease by CD8+ T cells. J. Autoimmun. 45 (2013), 68–79.
234. Drobits, B., Holcmann, M., Amberg, N., Swiecki, M., Grundtner, R., Hammer, M., Colonna, M., Sibilia, M., Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J. Clin. Investig. 122 (2012), 575–585.
235. Chaperot, L., Blum, A., Manches, O., Lui, G., Angel, J., Molens, J.P., Plumas, J., Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J. Immunol. 176 (2006), 248–255.
236. Kalb, M.L., Glaser, A., Stary, G., Koszik, F., Stingl, G., TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-alpha-mediated antitumor reactivity. J. Immunol. 188 (2012), 1583–1591.
237. Riboldi, E., Daniele, R., Cassatella, M.A., Sozzani, S., Bosisio, D., Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. Immunobiology 214 (2009), 868–876.
238. Zahn, S., Rehkamper, C., Ferring-Schmitt, S., Bieber, T., Tuting, T., Wenzel, J., Interferon-alpha stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus. Br. J. Dermatol. 165 (2011), 1118–1123.
239. Karrich, J.J., Jachimowski, L.C., Nagasawa, M., Kamp, A., Balzarolo, M., Wolkers, M.C., Uittenbogaart, C.H., Marieke van Ham, S., Blom, B., IL-21-stimulated human plasmacytoid dendritic cells secrete granzyme B, which impairs their capacity to induce T-cell proliferation. Blood 121 (2013), 3103–3111.
240. Salvi, V., Vermi, W., Cavani, A., Lonardi, S., Carbone, T., Facchetti, F., Bosisio, D., Sozzani, S., IL-21 may promote granzyme B-Dependent NK/plasmacytoid dendritic cell functional interaction in cutaneous lupus erythematosus. J. Investig. Dermatol. 137 (2017), 1493–1500.
241. Caruso, R., Botti, E., Sarra, M., Esposito, M., Stolfi, C., Diluvio, L., Giustizieri, M.L., Pacciani, V., Mazzotta, A., Campione, E., Macdonald, T.T., Chimenti, S., Pallone, F., Costanzo, A., Monteleone, G., Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat. Med. 15 (2009), 1013–1015.
242. Bratke, K., Nielsen, J., Manig, F., Klein, C., Kuepper, M., Geyer, S., Julius, P., Lommatzsch, M., Virchow, J.C., Functional expression of granzyme B in human plasmacytoid dendritic cells: a role in allergic inflammation, Clinical and experimental allergy. J. Br. Soc. Allergy Clin. Immunol. 40 (2010), 1015–1024.
243. Wahren-Herlenius, M., Dorner, T., Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 382 (2013), 819–831.
244. Boivin, W.A., Cooper, D.M., Hiebert, P.R., Granville, D.J., Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma. Lab. Investig.; a J. Tech. Methods Pathol. 89 (2009), 1195–1220.
245. Wu, Y.W., Tang, W., Zuo, J.P., Toll-like receptors: potential targets for lupus treatment. Acta Pharmacol. Sin. 36 (2015), 1395–1407.
246. Coutant, F., Miossec, P., Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles. Nat. Rev. Rheumatol. 12 (2016), 703–715.
247. Giannoukakis, N., Phillips, B., Finegold, D., Harnaha, J., Trucco, M., Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 34 (2011), 2026–2032.
248. Giannoukakis, N., Immunoregulatory dendritic cells to treat autoimmunity are ready for the clinic. Interview by Katie Lockwood. Immunotherapy 5 (2013), 919–921.
249. Benham, H., Nel, H.J., Law, S.C., Mehdi, A.M., Street, S., Ramnoruth, N., Pahau, H., Lee, B.T., Ng, J., Brunck, M.E., Hyde, C., Trouw, L.A., Dudek, N.L., Purcell, A.W., O'Sullivan, B.J., Connolly, J.E., Paul, S.K., Le Cao, K.A., Thomas, R., Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients. Sci. Transl. Med., 7, 2015, 290ra87.
250. Bell, G.M., Anderson, A.E., Diboll, J., Reece, R., Eltherington, O., Harry, R.A., Fouweather, T., MacDonald, C., Chadwick, T., McColl, E., Dunn, J., Dickinson, A.M., Hilkens, C.M., Isaacs, J.D., Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis. Ann. Rheum. Dis. 76 (2017), 227–234.
251. Figueroa-Vega, N., Galindo-Rodriguez, G., Bajana, S., Portales-Perez, D., Abud-Mendoza, C., Sanchez-Torres, C., Gonzalez-Amaro, R., Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus. Scand. J. Immunol. 64 (2006), 668–676.
252. Wu, H., Lo, Y., Chan, A., Law, K.S., Mok, M.Y., Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro. Immunology 149 (2016), 48–61.
253. Mackern-Oberti, J.P., Llanos, C., Vega, F., Salazar-Onfray, F., Riedel, C.A., Bueno, S.M., Kalergis, A.M., Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases. Autoimmun. Rev. 14 (2015), 127–139.
254. Lee, W.P., Willekens, B., Cras, P., Goossens, H., Martinez-Caceres, E., Berneman, Z.N., Cools, N., Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on dendritic cells promote Induction of T Cell hyporesponsiveness to myelin-derived antigens. J. Immunol. Res., 2016, 2016, 5392623.
255. Sozzani, S., Sallusto, F., Luini, W., Zhou, D., Piemonti, L., Allavena, P., Van Damme, J., Valitutti, S., Lanzavecchia, A., Mantovani, A., Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 155 (1995), 3292–3295.
256. Wang, Y., Ewart, D., Crabtree, J.N., Yamamoto, A., Baechler, E.C., Fazeli, P., Peterson, E.J., PTPN22 variant R620W is associated with reduced toll-like receptor 7-induced type I interferon in systemic lupus erythematosus. Arthritis Rheumatol. 67 (2015), 2403–2414.